Infobip becomes Platinum Partner of Rakuten Viber
Global cloud communications platformInfobip has become a Platinum Partner of Rakuten Viber. As a Platinum Partner, Infobip will be able to offer its customers early access to new products and features as well as getting priority access to a knowledge center. Infobip's elevation to Platinum Partner marks another achievement in its ongoing mission to enhance digital communication strategies for businesses worldwide.
CEO of Rakuten Viber, Ofir Eyal, presented Infobip with Viber’s Platinum Partnership Excellence Award at a recent Infobip and Rakuten Viber event. This recognition highlights groundbreaking innovation, significant business growth, and the strong collaboration between Infobip and Rakuten Viber.
Cristina Constandache, Chief Revenue Officer at Rakuten Viber, said: "At Rakuten Viber, we believe that strong partnerships are key to driving mutual growth. Our collaboration with Infobip has fuelled significant innovation and expansion. Infobip achieving the Platinum Partnership status shows our shared commitment to revolutionizing customer engagement with advanced technology and integrated communication solutions."
Silvija Renuša, Business Unit Head of Digital Channels at Infobip, said: "The strong partnership between Infobip and Viber underscores our shared commitment to future-focused, seamless customer experiences. We're proud to have reached the Platinum Partner status in the Rakuten Viber Partner Growth Program, and we look forward to continuing working closely with Viber and shaping the future of customer engagement together."
Over eight years, Rakuten Viber has integrated with Infobip's platform, becoming a key OTT channel. The collaboration has enabled businesses to use Viber for direct, rich media interactions with customers, enhancing user experiences, and helping customers in their digital transformation journey.
One recent example is Metrobank, the second-largest private universal bank in the Philippines. Metrobank partnered with Infobip to integrate Viber rich business messaging into its customer communication strategy, enhancing its operations with a trusted and secure digital platform. Utilizing Infobip's plug-and-play solution, Metrobank seamlessly incorporated Viber business messages into its existing processes with minimal effort. In no time, the bank began delivering personalized, rich content messages, including images and videos, to millions of consenting customers. This strategic move not only created a unique customer experience but also resulted in up to 50% cost savings compared to traditional SMS messaging, as Metrobank effectively communicated its latest offerings through Viber's rich media capabilities.
Ramon Martin Rodriguez, Performance Marketing Head at Metrobank, said: "Infobip provided a solution that enabled us to quickly start benefitting from using Viber for Business for sending marketing messages, using both a portal and an integration with our CRM system. The integration was extremely easy to set up with no disruption to our businesses processes, and no requirement to involve technical resources from other departments. We have been very satisfied with the entire process."
Learn more about the Metrobank success story: https://www.infobip.com/customer/metrobank
About Infobip
Infobip is a global cloud communications platform that enables businesses to build connected experiences across all stages of the customer journey.
About Rakuten Viber
Rakuten Viber is one of the most trusted and downloaded apps in the world. We create meaningful connections, bringing people together safely, so they can enjoy precious moments with their families and friends, manage their business relations, or pursue their passions, in one place - we do it all! As a super app, we give our users services that cover every aspect of their day-to-day needs and make their lives easier. Rakuten Viber is part of Rakuten Group, Inc., a global technology leader in e-commerce, fintech, digital content, and communications services.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250409859460/en/
Contacts
For more information, contact:
Marcelo Nahime
marcelo.nahime@infobip.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
www.businesswire.com
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
A-CAP Announces Successful Divestiture of Standard de Liège SA and Immobilière du Standard de Liège SRL6.6.2025 23:32:00 EEST | Press release
Advantage Capital Holdings, LLC (“A-CAP” or “The Company”), a New York-based insurance and financial services company with over $12 billion in assets, today announced the successful divestiture of Standard de Liège SA (“Standard Liège” or the “Club”), one of Belgium's most historic soccer clubs, and Immobilière du Standard de Liège SRL, the corporate entity that owns the Club's stadium, Maurice Dufrasne Stadium, to a consortium of buyers led by Standard Liège Chief Executive Officer Giacomo Angelini. This transaction marks the end of 777 Partners’ legacy involvement with the Club and sets the stage for the Club’s future growth and success, both on and off the field. Benefits of the transaction include: Increased stability across the Club’s shareholder base, which clears the path for future investments, Operational clarity, establishing a unified direction that will allow both players and management to fully concentrate on on-field performance, ensuring that collective focus remains on
Populous Acquires Fentress Architects, Expanding Global Aviation Portfolio6.6.2025 21:00:00 EEST | Press release
Populous, the world-renowned design firm specializing in sport and entertainment venues, today announced the acquisition of Denver-based Fentress Architects, a global leader in iconic aviation projects and prominent public buildings, including convention centers, museums and government facilities. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250606849000/en/ Los Angeles International Airport. Designed by Fentress Architects. This strategic acquisition unites two of the most respected names in architecture, combining Populous’ unparalleled expertise in designing memorable experiences with Fentress’ award-winning portfolio of aviation, civic and cultural landmarks. The acquisition significantly broadens the scope and scale of services that Populous can offer clients across the globe. Bruce Miller, Populous Global Chair and CEO, commented: “We are committed to expanding the breadth of our practice. Fentress Architects has lon
Vertex Presents New Data on Benefits of ALYFTREK ® and Importance of Achieving Lower Sweat Chloride Levels at the European Cystic Fibrosis Conference6.6.2025 19:00:00 EEST | Press release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced data across multiple studies demonstrating positive clinical and quality of life benefits of treatment with CFTR modulators and, in particular, ALYFTREK® (vanzacaftor/tezacaftor/deutivacaftor), which is approved in the United States and United Kingdom and is currently under review with health authorities in the EU, Canada, Australia, New Zealand and Switzerland. These data were presented at this year’s European Cystic Fibrosis Society’s (ECFS) 48th European Cystic Fibrosis Conference held June 4-7, 2025, in Milan, Italy. During the conference, the Company presented data from a pooled analysis across CFTR modulators, including ALYFTREK, which demonstrate that reduction in sweat chloride (SwCl), and therefore greater restoration of CFTR function, is associated with improved outcomes in people with cystic fibrosis (CF). For all clinical outcomes in the study, SwCl levels below 60 mmol/L were associated with greater benefit
IBSA Derma at IMCAS Asia 2025: spotlight on the future of aesthetic medicine in the 10 th Anniversary Year of NAHYCO ® Technology6.6.2025 17:00:00 EEST | Press release
IBSA Derma – the dermoaesthetic division of IBSA – once again confirms its leadership in the international aesthetic medicine landscape by participating in the 18th edition of IMCAS Asia, taking place from June 6 to 8 in Bangkok, Thailand. With over 3,000 attendees expected, the event represents a key opportunity for physicians and experts to share the latest innovations and cutting-edge advancements in aesthetic procedures and treatments, staying at the forefront of this dynamic field. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250603094257/en/ IBSA’s stand at IMCAS Asia 2025 As part of the congress, IBSA Derma will host a scientific symposium titled “The Future of Tissue Regeneration with NAHYCO® Technology. Feeling and Seeing the Results with Profhilo® Line” scheduled for Saturday, June 7, from 3:00 to 4:00 pm ICT in Room 1 - Level 2. Internationally renowned speakers – Dr. Lam Bee Lan and Prof. Ofir Artzi – will lead
HistoSonics Completes Enrollment in #HOPE4KIDNEY Trial Evaluating Non-Invasive Histotripsy to Treat Kidney Tumors6.6.2025 15:00:00 EEST | Press release
HistoSonics, Inc., the manufacturer of the Edison® Histotripsy System and novel histotripsy therapy platforms, today announced the completion of patient enrollment in its pivotal #HOPE4KIDNEY trial. This prospective, multi-center, single-arm trial is designed to evaluate the safety and effectiveness of the Edison System in destroying kidney tissue by treating primary solid kidney tumors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250606659747/en/ Edison Histotripsy System Procedure for Kidney Tumor Animation The trial enrolled patients with a single, non-metastatic solid kidney mass ≤3 cm, confirmed by imaging and biopsy. Subjects will be followed for five years post-procedure, with evaluations at multiple time points, including 14-day, 30-day, 90-day, 180-day, and annual assessments. The Edison System remains in investigational use for kidney applications and is not yet FDA-approved for this indication. Data from the #H
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom